Formycon Future Growth
Future criteria checks 4/6
Formycon is forecast to grow earnings and revenue by 77.6% and 18.8% per annum respectively. EPS is expected to grow by 108.4% per annum. Return on equity is forecast to be 8.1% in 3 years.
Key information
77.6%
Earnings growth rate
108.38%
EPS growth rate
Biotechs earnings growth | 21.3% |
Revenue growth rate | 18.8% |
Future return on equity | 8.10% |
Analyst coverage | Good |
Last updated | 12 May 2025 |
Recent future growth updates
Recent updates
Expected Launches Of Stelara And Keytruda Biosimilars Will Strengthen Future Pipeline
Jan 18 The launch of biosimilars and strategic focus on high-growth areas indicate strong future revenue and earnings potential for Formycon.A Look At The Fair Value Of Formycon AG (ETR:FYB)
Jul 20Formycon AG's (ETR:FYB) Prospects Need A Boost To Lift Shares
May 29We Believe Formycon's (ETR:FYB) Earnings Are A Poor Guide For Its Profitability
May 03Some Confidence Is Lacking In Formycon AG's (ETR:FYB) P/S
Jan 19We Think Formycon (ETR:FYB) Needs To Drive Business Growth Carefully
Dec 23Formycon AG's (ETR:FYB) Share Price Not Quite Adding Up
Sep 26We Think You Should Be Aware Of Some Concerning Factors In Formycon's (ETR:FYB) Earnings
Nov 05We're Hopeful That Formycon (ETR:FYB) Will Use Its Cash Wisely
Sep 04Analysts Just Published A Bright New Outlook For Formycon AG's (ETR:FYB)
Jul 13Bearish: Analysts Just Cut Their Formycon AG (ETR:FYB) Revenue and EPS estimates
Jun 02Here's Why We're Not Too Worried About Formycon's (ETR:FYB) Cash Burn Situation
May 23Here's Why We're Not At All Concerned With Formycon's (ETR:FYB) Cash Burn Situation
Feb 01We Think Formycon (ETR:FYB) Can Easily Afford To Drive Business Growth
Sep 25We're Interested To See How Formycon (ETR:FYB) Uses Its Cash Hoard To Grow
May 19Is Formycon's (ETR:FYB) 179% Share Price Increase Well Justified?
Jan 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 130 | 36 | 14 | 75 | 7 |
12/31/2026 | 99 | 15 | 8 | 37 | 7 |
12/31/2025 | 58 | -22 | -23 | -15 | 7 |
12/31/2024 | 70 | -126 | -53 | -23 | N/A |
9/30/2024 | 65 | -31 | -56 | -28 | N/A |
6/30/2024 | 61 | 64 | -59 | -33 | N/A |
3/31/2024 | 69 | 70 | -45 | -21 | N/A |
12/31/2023 | 78 | 76 | -31 | -10 | N/A |
9/30/2023 | 73 | 17 | -43 | -13 | N/A |
6/30/2023 | 69 | -42 | -54 | -17 | N/A |
3/31/2023 | 56 | -3 | -50 | -18 | N/A |
12/31/2022 | 42 | 36 | -46 | -19 | N/A |
9/30/2022 | 38 | 57 | -32 | -17 | N/A |
6/30/2022 | 34 | 77 | -19 | -16 | N/A |
3/31/2022 | 35 | 32 | -17 | -15 | N/A |
12/31/2021 | 37 | -13 | -14 | -13 | N/A |
9/30/2021 | 37 | -15 | N/A | N/A | N/A |
6/30/2021 | 38 | -15 | -12 | -11 | N/A |
3/31/2021 | 36 | -11 | -9 | -8 | N/A |
12/31/2020 | 34 | -7 | -5 | -4 | N/A |
9/30/2020 | 33 | -4 | N/A | N/A | N/A |
6/30/2020 | 32 | -3 | 12 | 13 | N/A |
3/31/2020 | 33 | -3 | 5 | 6 | N/A |
12/31/2019 | 33 | -2 | -2 | -1 | N/A |
9/30/2019 | 34 | -2 | N/A | N/A | N/A |
6/30/2019 | 36 | -1 | -17 | -16 | N/A |
3/31/2019 | 39 | 3 | -2 | -1 | N/A |
12/31/2018 | 43 | 7 | 12 | 13 | N/A |
9/30/2018 | 44 | 8 | N/A | 11 | N/A |
6/30/2018 | 45 | 9 | N/A | 8 | N/A |
3/31/2018 | 37 | 4 | N/A | 2 | N/A |
12/31/2017 | 29 | -2 | N/A | -4 | N/A |
9/30/2017 | 24 | -4 | N/A | -3 | N/A |
6/30/2017 | 19 | -6 | N/A | -2 | N/A |
3/31/2017 | 19 | -5 | N/A | -4 | N/A |
12/31/2016 | 20 | -4 | N/A | -5 | N/A |
9/30/2016 | 18 | -3 | N/A | -4 | N/A |
6/30/2016 | 16 | -2 | N/A | -2 | N/A |
3/31/2016 | 16 | -1 | N/A | -1 | N/A |
12/31/2015 | 17 | 1 | N/A | 1 | N/A |
9/30/2015 | 19 | 0 | N/A | 0 | N/A |
6/30/2015 | 22 | 0 | N/A | 0 | N/A |
3/31/2015 | 17 | 0 | N/A | 0 | N/A |
12/31/2014 | 13 | 1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FYB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
Earnings vs Market: FYB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: FYB is expected to become profitable in the next 3 years.
Revenue vs Market: FYB's revenue (18.8% per year) is forecast to grow faster than the German market (5.8% per year).
High Growth Revenue: FYB's revenue (18.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FYB's Return on Equity is forecast to be low in 3 years time (8.1%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/12 18:21 |
End of Day Share Price | 2025/05/12 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Formycon AG is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Gerhard Orgonas | Berenberg |
Benjamin Thielmann | Berenberg |
Simon Scholes | First Berlin Equity Research GmbH |